Image name
Image name

Cultural Heritage

Image name

Cultural Heritage


Name

File size

Download

Qizheng Tibetan Medicine: Notice Regarding the Commencement of Conversion of Qizheng Convertible Bonds

196.6KB

Qizheng Tibetan Medicine: Attestation Report by Zhongqin Wanxin Certified Public Accountants Regarding Tibet Qizheng Tibetan Medicine Co., Ltd.'s Replacement of Previously Paid Issuance Expenses with Funds Raised

157.7KB

Qizheng Tibetan Medicine: Verification Opinion of Shenwan Hongyuan Securities Underwriting & Sponsorship Co., Ltd. Regarding the Use of Raised Funds by Tibet Qizheng Tibetan Medicine Co., Ltd. to Replace Previously Paid Issuance Expenses

157.7KB

Qizheng Tibetan Medicine: Announcement Regarding the Establishment of a Dedicated Settlement Account for Cash Management of Idle Raised Funds by a Subsidiary

150.5KB

Qizheng Tibetan Medicine: Notice on the Listing and Circulation of Shares Released from Sale Restrictions in the First Vesting Period of the Reserved Grant Portion of the 2019 Restricted Stock Incentive Plan

234.2KB

Qizheng Tibetan Medicine: Progress Announcement Regarding the Use of Part of Idle Raised Funds by a Subsidiary for Cash Management

231.8KB

Qizheng Tibetan Medicine: Announcement of Resolutions from the 32nd Meeting of the 4th Board of Directors

141.7KB

Qizheng Tibetan Medicine: Announcement of Resolutions from the 27th Meeting of the 4th Supervisory Board

132.9KB

Qizheng Tibetan Medicine: Announcement Regarding Participation in the Establishment of an Equity Investment Fund

264.0KB

Qizheng Tibetan Medicine: Legal Opinion of Beijing Hairun Tianrui Law Firm Regarding the Fulfillment of Conditions for Lifting the Restriction on Sale of the First Vesting Period of the Reserved Grant Portion of the 2019 Restricted Stock Incentive Plan of Tibet Qizheng Tibetan Medicine Co., Ltd.

320.3KB

Qizheng Tibetan Medicine: Independent Opinion of the Independent Directors on Matters Relating to the 32nd Meeting of the 4th Board of Directors

124.3KB

Qizheng Tibetan Medicine: Announcement Regarding the Fulfillment of Vesting Conditions for the First Vesting Period of the Reserved Grant Portion of the 2019 Restricted Stock Incentive Plan

237.1KB

Qizheng Tibetan Medicine: Progress Announcement Regarding the Use of Part of Idle Raised Funds by a Subsidiary for Cash Management

210.1KB

Qizheng Tibetan Medicine: Progress Announcement Regarding the Use of Part of Idle Raised Funds by a Subsidiary for Cash Management

210.1KB

Qizheng Tibetan Medicine: 2020 Annual Performance Quick Report

146.3KB

Qizheng Tibetan Medicine: Announcement Regarding the Establishment of a Dedicated Settlement Account for Cash Management of Idle Raised Funds by a Subsidiary

162.5KB

Qizheng Tibetan Medicine: Legal Opinion on the First Extraordinary Shareholders’ Meeting of 2021

172.7KB

Qizheng Tibetan Medicine: Announcement of Resolutions Adopted at the First Extraordinary General Meeting of Shareholders in 2021

148.1KB

Qizheng Tibetan Medicine: Verification Opinion of Shenwan Hongyuan Securities Underwriting & Sponsorship Co., Ltd. Regarding the Use of Excess Funds by the Company’s Subsidiary to Repay Special Loans for the Company’s Pharmaceutical Industry Base Construction Project

227.5KB

Qizheng Tibetan Medicine: Announcement Regarding the Use of Raised Funds Exceeding the Target Amount by the Subsidiary to Repay the Special Loan for the Qizheng Tibetan Medicine Pharmaceutical Industry Base Construction Project

222.9KB

Qizheng Tibetan Medicine: Announcement Regarding the Use of Part of Idle Raised Funds by a Subsidiary for Cash Management

207.6KB

Qizheng Tibetan Medicine: Announcement of Resolutions from the 26th Meeting of the 4th Supervisory Board

151.1KB

Qizheng Tibetan Medicine: Verification Opinion of Shenwan Hongyuan Securities Underwriting & Sponsorship Co., Ltd. Regarding the Company’s Cross-License Use of Trademarks and Related Party Transactions

390.3KB

Qizheng Tibetan Medicine: Verification Opinion of Shenwan Hongyuan Securities Underwriting & Sponsorship Co., Ltd. Regarding the Use of Part of Idle Raised Funds by the Company’s Subsidiary for Cash Management

209.0KB

< 1...111213...56 >